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Abstract 
Background: The success of current control tools in combatting malaria vectors is well established. However, 
sustained residual transmission of Plasmodium parasites persists. Mass drug administration (MDA) to humans of the 
endectocide ivermectin for vector control is receiving increasing attention. However, vectors feeding upon animals 
escape this promising approach. Zoophagy of mosquitoes sustains both the vector population and endemic popula‑
tion of vector‑borne pathogens. Therefore, only a strategy that will combine ivermectin MDAs targeted at humans 
and their peridomestic animals could be successful at controlling residual malaria transmission.
Methods: Burkinabé cattle have been treated with injectable therapeutic dose of ivermectin (0.2 mg/kg of body 
weight) to render blood meals toxic to field representative populations of Anopheles coluzzii carrying the kdr muta‑
tion. Direct skin‑feeding assays were performed from 2 to 28 days after injection (DAI) and mosquitoes were followed 
for their survival, ability to become gravid and fecundity. Membrane feeding assays were further performed to test if 
an ivermectin blood meal taken at 28 DAI impacts gametocyte establishment and development in females fed with 
infectious blood.
Results: The mosquitocidal effect of ivermectin is complete for 2 weeks after injection, whether 12 days cumulative 
mortalities were of 75 and 45 % the third and fourth weeks, respectively. The third week, a second ivermectin blood 
meal at sub‑lethal concentrations further increased mortality to 100 %. Sub‑lethal concentrations of ivermectin also 
significantly decreased egg production by surviving females, increasing further the detrimental effect of the drug on 
vector densities. Although females fitness was impaired by sub‑lethal ivermectin blood meals, these did not diminish 
nor increase their susceptibility to infection.
Conclusion: This study demonstrates the potential of integrated MDA of ivermectin to both human and peridomes‑
tic cattle to target vector reservoirs of residual malaria transmission. Such integration lies in ‘One‑Health’ efforts being 
implemented around the globe, and would be especially relevant in rural communities in Africa where humans are 
also at risk of common zoonotic diseases.
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Background
The success of long-lasting insecticidal nets (LLINs) and 
indoor residual spraying (IRS) in combatting malaria 
transmission by Anopheles mosquitoes is well estab-
lished. However, transmission of Plasmodium parasites 
persists despite effective coverage being achieved with 
LLINs and IRS interventions. Besides the evolution of 
physiological resistance allowing a mosquito to survive 
despite direct contact with insecticides (either by target 
site mutations and/or metabolic resistance [1]), vectors 
responsible for residual transmission can exhibit specific 
behaviours, such as biting at unusual times, that allow 
them to escape the fatal exposure to LLINs or IRS [2, 3]. 
Insecticide avoidance, exophily, exophagy, but also zoo-
phagy [4], are all behaviours that minimize the contact 
between the mosquito and the insecticides, and contrib-
ute to the build-up of reservoirs of vector populations 
responsible for residual transmission of diseases.
In this context, mass drug administration (MDA) of 
endectocidal drugs to humans for human malaria control 
is receiving increasing attention [5, 6]. Endectocides are 
drugs that have activity against endo- and ectoparasites 
among which ivermectin was first introduced for com-
mercial use as an anti-parasitic drug for animal (live-
stock and pets) use in 1981. This molecule shares with 
other avermectins and mylbemicins a pharmacophore 
consisting on 16-membered macrocyclic lactone, and is 
an agonist of specific chloride ion channels (primarily 
glutamate-gated chloride channels). As these channels 
are neurotransmission inhibitors, ivermectin leads to 
flaccid paralysis, which culminates in the animal death 
[7]. Ivermectin is the only known endectocide currently 
approved for human use and is now massively distributed 
as part of pan-African programs for onchocerciasis con-
trol and lymphatic filariasis elimination [8, 9]. The broad 
range of invertebrates it targets includes mosquito vec-
tors of diseases, such that ivermectin is now proposed as 
an additional tool to control vector-borne diseases such 
as malaria [5, 6, 10–15]. Hence, numerous in  vitro and 
in  vivo studies have shown that a blood meal contain-
ing ivermectin causes a significant reduction in adult 
female mosquito longevity, fecundity and fertility [5]. 
In experimental infections of malaria mosquitoes, iver-
mectin was also shown to inhibit Plasmodium sporo-
gony [16]. Recent field-based studies have demonstrated 
that MDA using ivermectin can significantly reduce the 
survivorship of adult field-caught Anopheles mosquitoes 
[11, 12, 14, 15]. Ivermectin, thus, seems to negatively 
affect a series of mosquito traits (longevity, fecundity, 
competence to pathogens), which are keys in determin-
ing the intensity of disease transmission. In other words, 
ivermectin can reduce mosquito vectorial capacity. The 
straightforward rationale of using ivermectin MDA for 
vector control lies on the fact that the treated human 
directly delivers the toxic molecule to any human-feeding 
mosquito regardless of its genus, species, and possibly for 
a large spectrum of the behavioural resistance it might 
display, i.e., mosquitoes of diurnal or nocturnal activities, 
resting indoors or outdoors, feeding indoors or outdoors, 
could be targeted.
The glutamate-gated chloride channel, primary targets 
of ivermectin, has recently been characterized in Anoph-
eles gambiae, where it is expressed in motor and sensory 
neurons [17]. Like for other invertebrates [18, 19], iver-
mectin has been shown to potentiate glutamate action in 
malaria mosquitoes [17]. This mode of action is distinct 
compared to current (and candidate) insecticides for 
IRS application (pyrethroids, organochlorines, organo-
phosphates, and carbamates) and LLIN treatment (pyre-
throids), making ivermectin administration a promising 
tool for integrated vector control and insecticide resist-
ance management in malaria vectors.
However, vectors feeding upon animals will still escape 
this approach. Anopheles mosquitoes are able to feed 
on many other vertebrates than humans and second-
ary malaria vectors feed primarily on animals, outdoors. 
Because they only feed occasionally on humans these 
mosquitoes are poor disease vectors, but since they 
respond poorly to LLIN or IRS interventions, they are 
therefore responsible for limited but self-sustaining dis-
ease transmission [4]. Highly anthropophilic Anopheles 
species also display zoophilic and outdoor blood-feeding 
behaviour in response to the altered patterns of blood 
source availability following IRS or LLIN implementa-
tion [20]. For example, a study conducted in an area of 
extensive coverage with LLINs showed that whereas 
the anthropophilic rate (as measured with odour-baited 
entry traps) of Anopheles coluzzii was 88  %, over 50  % 
fed on cattle, indicating a plastic feeding strategy with 
a zoophilic pattern of host selection despite a stronger 
response to human odour. In this field population, An. 
coluzzii has an innate preference for humans but the 
weak accessibility of this host species, due to the use 
of bed nets, forces the mosquitoes to feed on cattle, an 
available, less preferred host [21]. Zoophagy of mosqui-
toes, either innate or induced by control interventions, 
can therefore sustain the build-up of a reservoir of vector 
populations responsible for the residual transmission of 
parasites.
Ivermectin is also widely used by veterinarian services 
for the control of parasites of companion animals and 
livestock [22]. Therefore, animal treatment with iver-
mectin as a supplementary tool for controlling vectors 
of human disease would be rather straightforward to 
implement and, hence, this approach has received lit-
tle attention [4, 5, 23]. However, it is not yet considered 
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as an intrinsic, mandatory part of future malaria vector 
control approaches using MDA of ivermectin distributed 
to humans. Such integration would lie in ‘One-Health’ 
efforts being implemented around the globe, and would 
be especially relevant in rural farming communities in 
Africa where humans are also at risk of common zoonotic 
diseases.
In Burkina Faso, around 77 % of the population live in 
rural areas [24], where people mainly rely on small family 
farming for their livelihoods, based on cereals and cotton 
cropping, livestock breeding and tree product collection. 
Almost each farm household owns a pair of oxen dedi-
cated to field labour. The present work explores the pos-
sibility of integrated ivermectin MDA measures, which 
would benefit humans and animals in rural areas of Bur-
kina Faso. Other studies have dealt with the impact of iver-
mectin on life history traits of Anopheles gambiae s.l. fed 
on cattle [22, 25–27] and on their vector competence for 
laboratory strain of P. falciparum [16]. However, the pre-
sent study uses a combination of sympatric, recently estab-
lished mosquito colonies, local calves and field-collected 
strains of P. falciparum, with the aim of being as relevant 
as possible in establishing the proof of concept that iver-
mectin-treated cattle could be used as an additional tool to 
circumvent residual malaria transmission in rural Africa.
Methods
Mosquito colony
The An. coluzzii colony hosted at the Institut de Recherche 
en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina 
Faso insectary facility was used. This colony was estab-
lished in 2008 and repeatedly replenished with F1 from 
wild-caught mosquito females collected in Kou Valley 
(11°23′14″N, 4°24′42″W), 30  km from Bobo-Dioulasso, 
southwestern Burkina Faso (West Africa), and identified 
for their species status by routine PCR [28]. Potential con-
tamination of the colony by other Anopheles species was 
routinely checked using the same technique. Mosqui-
toes were maintained under the standard conditions of 
27 ± 2 °C, 75 ± 5 % relative humidity and 12 h/12 h day/
night cycle. Larvae were reared at low densities in plas-
tic trays in tap water and fed ad libitum with commercial 
alevin food [Tetramin® Baby Fish Food (Tetrawerke, Melle, 
Germany)]. Pupae were collected in cups and placed 
in 30  ×  30  ×  30  cm cages. Newly emerged adults were 
allowed to feed for three to 5 days on 5 % glucose solution 
then starved for 16–18 h before blood feeding on cattle.
Thirty-two females were randomly chosen in the col-
ony to characterize their physiological resistance status 
by PCR following [29] for the kdr mutation and for ace1 
[30]. Eight females carried the mutated kdr allele, and all 
carried the wild alleles of the ace-1 gene. The kdr muta-
tion checked for in the colony refers to the West-African 
kdr mutation (i.e. kdr-W or L1041F), as the kdr-E (or 
L1041S, first evidenced in East-Africa) has not yet been 
reported in the area of Bama for An. coluzzii [31].
Cattle hosts
Four bull calves (mean weight = 91 ± 24 kg) of the local 
Metis breed (obtained from cross breedings between 
Fulani zebus and Baoulé bulls) were used as hosts for 
Anopheles blood feeding. Upon their arrival to the Centre 
International de Recherche-Développement sur l’Elevage 
en zones Subhumides (CIRDES) stable facilities, (i.e., 
1 month before the start of experiments), the calves were 
systematically treated with therapeutic doses of aceturate 
diminazene and albendazole to, respectively, cure poten-
tial trypanosomiasis (endemic in this area) and gastro-
intestinal infestation with endoparasites, which could 
affect their well-being. During the experiment, calves 
were fed with a diet made of straw and cotton oil cake 
and provided with water ad  libitum. They were main-
tained in the stable, protected by a net to avoid any insect 
disturbance, and checked every other day by a veterinar-
ian to ensure their well-being.
Ivermectin treatment
Two calves were randomly chosen to receive a subcuta-
neous injection of ivermectin (IVOMEC D®) at the thera-
peutic dose of 0.2 mg/kg of body weight (treated calves, 
A and C), while the two other calves received no treat-
ment (controls, B and D).
Blood feeding
Three to five days old mosquitoes were randomly intro-
duced into 16 plastic cups covered with nets (n  =  30 
mosquitoes per cup). Four plastic cups were randomly 
assigned to each control and treated calf and disposed 
on the sides of the calves, where they were held using a 
rubber strap arranged around the animals’ abdomen. 
Calves were restrained using ropes to avoid rough move-
ments and scratching. Mosquitoes were allowed to feed 
for 15 min, after which only fully engorged females were 
transferred in maintaining cups or cages, for survival and 
fecundity evaluation, respectively (Fig.  1 for a diagram-
matic representation of the experimental set-up). Blood 
feeding of mosquitoes occurred in six instances: once 
before treatment and at different times points after iver-
mectin treatment, taking into account previous experi-
ments (Additional files 1 and 2), and already published 
plasmatic pharmacokinetics of the molecule in cattle 
[32]: i.e, at 2, 7,14, 21, and 28  days after the injection 
(DAI). Different batches of mosquitoes were used for 
each blood-feeding episode. The percentage of blood-fed 
mosquitoes was similar between the seven batches (i.e. 
95 %), for each treatment and each calf.
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Life history traits of mosquitoes fed on treated and control 
cattle
Survival
Fully engorged females were randomly distributed, 
maintained in paper cups (cup volume was 455 cu). Four 
cups were used per calf with ten mosquitoes per cup 
(Fig. 1) and provided every day with cotton balls soaked 
in 2.5 % glucose solution. Mortality was recorded every 
day from the day of blood feeding until all mosquitoes 
died.
Reproduction
In An. gambiae s.l., the first blood meal is often used 
to compensate nutritional deficiencies carried over 
from larval stages instead of developing ovarian fol-
licles [33]. This was also observed in the IRSS’ An. 
coluzzii colony, for which only a small proportion of 
females developed eggs after only one blood meal [34]. 
For this reason and in line with previous studies [35], 
the number of eggs produced after two consecutive 
blood meals was considered as more representative of 
mosquito fecundity. Hence, 4  days after a first blood 
meal, female mosquitoes took a second blood meal 
on the same host than the first (Fig. 1). Dissections of 
the ovaries were performed 4  days afterwards, when 
the second blood meal was entirely digested. The sec-
ond blood meal success was similar to the first (i.e. 
90  %) and only females that had actually taken two 
blood meals were considered. Ovaries were extracted 
from the abdomen and dissected in a drop of Phos-
phate Buffered Saline (PBS) to release the eggs, which 
were counted under a binocular (40×, Leica S6D). 
The number of females carrying developed eggs (i.e., 
egg prevalence) and the number of mature eggs (i.e., 
Christopher stage V) developed by a female were con-
sidered as proxies of their fecundity [33]. As for sur-
vival experiments, for each mosquito lot (see above), 
fully engorged females were randomly distributed and 
maintained in paper cups (four cups per calf, ten to 15 
mosquitoes per cage) until the dissection.
Fig. 1 Diagrammatic representation of the sequential events forming the study’s experimental design. X represents either 0, 2, 7, 14 or 28 DAI 
whether Y is for the calf A, B, C or D
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Effect of a sub‑lethal dose of ivermectin on the sporogonic 
development of Plasmodium falciparum
Experimental infections of An. coluzzii females with P. 
falciparum gametocytes were processed by membrane 
feeding as previously described [36, 37]. Thick blood 
smears from 5–11  years old children from the village 
of Dandé (11°34′48″ N, 4°33′36″ W) were examined 
using light microscopy to identify gametocyte carriers. 
Gametocyte density was evaluated against 1000 white 
blood cells (WBC) and expressed per µl, assuming the 
canonical number of 8000 WBC/µl of blood. A gameto-
cyte carrier with 64 gametocytes/µl was selected for the 
experiment. Five ml of venous blood were collected and 
distributed in each membrane feeder and maintained at 
37  °C by circulating heated water. In nature, it is likely 
sequentially that a mosquito will absorb sub-lethal doses 
of ivermectin from a cattle host and, 2–4  days later, an 
infectious blood meal from a human host. For ethical 
considerations, only this “prophylactic” combination was 
tested (i.e. whether an ivermectin containing bloodmeal 
would protect the mosquito from a subsequent infection 
by Plasmodium falciparum), since other combinations 
(i.e. the ivermectin containing blood meal given the same 
day or 3–4 days after the infectious one (the later being 
the “therapeutic” combination)) would require poten-
tially infectious mosquitoes to be transported from IRSS 
to CIRDES. At 28 DAI, batches of mosquitoes that had 
already taken their first blood meal on treated and control 
cattle 4 days before (see above for blood feeding process-
ing) were infected. For that, mosquitoes were disposed 
under the feeders and allowed to feed for 30 min. Only 
fully engorged mosquitoes were followed up for parasite 
development, and for this purpose, were provided ad libi-
tum 5 % glucose solution for 8 days after membrane feed-
ing. Mosquito midguts were then dissected in a drop of 
0.5 % mercurochrome, mounted on a slide, covered with 
a coverslip and examined under a light microscope (20×, 
Leica ICC 50) to detect and count the oocysts.
Statistics
All statistical analysis were performed using the software 
R version 3.1.3 GUI 1.65.
Mosquito survival
Kaplan–Meier survival estimates were calculated to 
investigate whether females’ longevities were affected by 
a blood meal taken on cattle at different DAI of a thera-
peutic dose of ivermectin. Uncensored data were used, as 
all mosquitoes were dead by the end of the experiment. 
The effects of the ivermectin treatment, the time after 
injection and their interaction were further tested using 
Cox proportional hazards model. Because the blood from 
different cattle may represent different nutritive values, 
the effect of cattle on female survival was evaluated for 
each DAI and within each treatment status (i.e., ivermec-
tin-treated or control). This cattle effect on mosquito 
survival was also assessed for the four cattle before the 
ivermectin was injected (0 DAI) in order to ensure that 
any difference in mosquito survival was due, at least in 
part, to the ivermectin treatment.
Mosquito reproduction
First, the effect of the ivermectin treatment, the DAI 
and their interaction on the probability that a female will 
become gravid was examinated by fitting logistic regres-
sion models (generalized linear modelling with binomial 
errors and logit link function). Second, only females that 
were gravid were subsequently considered and regression 
models (generalized linear modelling with quasipoisson 
errors and logit link function) were used to examine the 
effect of ivermectin treatment, the DAI and their interac-
tion on the number of developed eggs. Cattle effect was 
also examined as described above.
Plasmodium sporogonic development
The impact of sub-lethal dose of ivermectin within a first 
blood meal taken at 28 DAI on the infectivity of P. fal-
ciparum parasites absorbed during a second blood meal 
(i.e., infection prevalence) was tested using generalized 
linear models with binomial errors and logit link func-
tion. Only females that were infected were subsequently 
considered to examine whether the first blood meal 
had an impact on the number of oocysts developed by 
infected females (i.e., infection intensity) through gener-
alized linear models (quasipoisson errors and logit func-
tion). As for survival and fecundity, the cattle effect has 
been examined as previously described.
For all the analysis, stepwise simplification of mod-
els was performed where non-significant terms were 
sequentially removed to produce the minimal model with 
the best explanatory power [38]. When needed, analysis 
were followed by post hoc tests procedures (multcomp 
package) to compare the levels of significant factors. 
Before the analysis, the constancy of variance between 
datasets was checked using the Fligner–Killeen test. 
When needed, a variable transformation was performed 
to meet this constancy.
Results
Survival
Experiments investigating the toxic effect of a blood 
meal taken from ivermectin-treated cattle included 
960 females followed after their blood meal and until 
their death. For the females fed on cattle before injec-
tion of ivermectin, the Cox proportional hazards 
model revealed no significant effect of cattle identity 
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on survival (χ23  =  1.42, p  =  0.69), which was on aver-
age 17.77 ±  1.52  days, 19.80 ±  0.88, 20.14 ±  1.22, and 
21.32  ±  0.73  days. Analysis of mosquito survival after 
ivermectin injection showed a significant effect of the 
treatment, DAI and the interaction between these two 
factors (Table  1). This significant treatment  ×  DAI 
interaction indicates a decrease in the negative impact 
of ivermectin on mosquito survival overtime (Fig.  2). 
The reduction of mosquito survival is significant and 
equal to 86.7 % at 2 DAI, 82.63 % at 7 DAI, and 54.35 % 
at 21  DAI. At 28 DAI, the mean survival is reduced by 
23.48 %, but this tendency is only marginally significant 
(Cox proportional hazards models for 28 DAI, treatment 
effect, χ21 = 3.76, p = 0.052). At 15 DAI, lower than usual 
mean survivals of 5.90  ±  1.52 and 12.75  ±  2.80  days 
were observed for the mosquitoes fed on, respectively, 
the control calves B and D, which led to underestimates 
of the ivermectin effect at this time period. In an addi-
tional experiment, mosquitoes fed on control calves at 
15 DAI had a usual mean survival of 16.6  ±  3.85  days 
(Additional file  2), allowing to estimate that feeding 
on treated calves 15 days after injection leads to a 77 % 
reduction in average of the mean survival time. For the 
mosquitoes fed both at 21 DAI and 28 DAI, significant 
differences appear between the batches fed on the treated 
calves A and C (mean survival of females fed on cattle A 
and C at 21 DAI = 5.34 ± 0.78 and 10.33 ± 0.95, respec-
tively, Cox proportional hazards models, cattle effect 
for this sub-set, χ21 = 11.35, p < 0.001; mean survival of 
females fed on cattle A and C at 28 DAI =  5.63 ±  0.55 
and 15.03  ±  1.75, respectively, Cox proportional haz-
ards models, cattle effect for this sub-set, χ21  =  25.53, 
p  <  0.001). At 28 DAI, the effect of the treated cattle C 
on mosquito survival was no more different from the 
controls (comparison of mean survival of mosquitoes fed 
on treated calf C and control calves B and D, p > 0.5 for 
both comparisons), but differed from cattle A (p < 0.001). 
As complementary information to better apprehend the 
consequences of ivermectin treatment in terms of reduc-
tion of vectors densities or sporogony, we also consid-
ered the time to 100 % mortality for each DAI. At 2 DAI, 
100 % of the mosquitoes would die in 2.87 ± 0.35 days, in 
4 ± 0.53, 5.5 ± 3.07, 17 ± 4.24 and in 19.5 ± 11.61 days 
at seven, 15, 21 and 28 DAI, respectively. By comparison, 
100 % mortality for the control treatment was achieved in 
32.12 ± 5.74, 24.37 ± 3.99, 24 ± 4.45, 27.87 ± 5.59 and 
27.12 ±  5.40 at two, seven, 15, 21 and 28 DAI, respec-
tively. For the 15 DAI time point, values from supplemen-
tal data were taken (see Additional files 1 and 2).
The effect of an additional blood meal taken on treated 
cattle was further investigated for its impact on the sur-
vival of vector mosquitoes (Additional files 1, 2 and 3). 
The significant treatment  ×  DAI  ×  number of blood 
meals is due to the fact that the impact of a second blood 
meal varies with the time elapsed since ivermectin injec-
tion: while it had no effect at one, seven and 15 DAI, it 
further decreased mosquito survival at 21 DAI and was 
beneficial (i.e., allows a higher survival than a single 
blood meal) at 31 and 38 DAI (Additional file 3).
Fecundity
Five hundred and forty-five mosquito females were ana-
lysed to investigate the effect of ivermectin treatment 
on their fecundity. The number of females that did not 
develop eggs was very low for females fed on cattle before 
ivermectin injection (i.e., three out of 92 females), but 
because these females were all from the batch fed on cat-
tle A, a significant effect of the cattle host on female egg 
prevalence was found (χ23 = 10.93, p = 0.012). However, 
the analysis further showed that the cattle host blood 
did not impact the number of eggs developed by the 
females (calf A 69.85 ± 11.13, calf B 89.73 ± 6.54, calf C 
85.35 ± 7.46, calf D 96.37 ± 7.61, χ23 = 18.7, p = 0.70). 
After ivermectin injection, only females fed on cattle at 
7, 21 and 28 DAI could be analysed due to the absence of 
surviving mosquitoes 4 days after the second blood feed-
ing in the other mosquito batches. A significant influ-
ence of the treatment (χ21 =  14.92, p  <  0.001), the DAI 
(χ21 = 45.40, p < 0.001) and their interaction (χ21 = 20.15, 
p < 0.001) was found on the probability of a female mos-
quito to become gravid. The treatment  ×  DAI interac-
tion was due to the fact that treated females fed at 7 DAI 
on treated cattle had a significant, lower probability of 
becoming gravid by comparison to their counterparts fed 
on control cattle (10 % (n = 10 females) vs. 89 % (n = 88 
females), χ21 = 28.69, p < 0.001), whereas the treatment 
effect was non-significant or marginally significant for 
mosquitoes fed at 21 and 28 DAI (χ21 =  1.77, p =  0.18 
and χ21  =  0.66, p  =  0.064, respectively). The effects of 
ivermectin treatment, the DAI and their interaction on 
the number of eggs developed by gravid females were 
further investigated by considering the subset of females 
that had developed at least one egg. Because a single 
female developed her eggs in the batch fed on treated cat-
tle at 7  DAI, this batch was excluded from the analysis. 
Table 1 Effects of ivermectin treatment, the DAI and their 
interaction on female An. coluzzii survival
DAI days after injection
* Significant effect of parameters or interactions (p < 0.05)
Source DF χ2 p value
Treatment 1 211.55 <0.0001*
DAI 4 107.97 <0.0001*
Treatment × DAI 4 167.87 <0.0001*
Page 7 of 12Pooda et al. Malar J  (2015) 14:496 
Hence, the analysis was performed on the 21 DAI and 
28 DAI batches only after a square-root transformation 
of the number of eggs per female. The model revealed 
no significant interaction between the treatment and 
the DAI, which was removed (χ21 = 1.49, p = 0.37). The 
minimal model (Table  2) revealed a significant effect of 
the treatment and the DAI on the number of eggs devel-
oped by An. coluzzii females. The DAI effect is due to the 
variability between the batches for the mean number of 
eggs developed by the females, whether the treatment 
effect remains constant between 21 and 28 DAI (33 and 
36 % reduction of the total number of eggs, respectively, 
Fig.  3). For the subset of mosquitoes fed on control or 
treated calves, there was no cattle effect for the number 
of gravid females, or for the number of eggs developed by 
gravid females (cattle effect for egg prevalence in control 
0 10 20 30 40
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Days after blood feeding
P
ro
po
rti
on
 o
f s
ur
vi
vi
ng
 m
os
qu
ito
es 2 DAI
0 10 20 30 40
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Days after blood feeding
P
ro
po
rti
on
 o
f s
ur
vi
vi
ng
 m
os
qu
ito
es 7 DAI
0 10 20 30 40
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Days after blood feeding
P
ro
po
rti
on
 o
f s
ur
vi
vi
ng
 m
os
qu
ito
es 15 DAI
0 10 20 30 40
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Days after blood feeding
P
ro
po
rti
on
 o
f s
ur
vi
vi
ng
 m
os
qu
ito
es 21 DAI
0 10 20 30 40
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Days after blood feeding
P
ro
po
rti
on
 o
f s
ur
vi
vi
ng
 m
os
qu
ito
es 28 DAI
Fig. 2 Kaplan–Meier estimates of Anopheles coluzzii survival when fed on treated and control cattle at different days after injection (DAI) of 200 µg/
kg of ivermectin. Black lines mosquitoes fed on control calves; grey lines mosquitoes fed on treated calves
Table 2 Effects of  ivermectin treatment and  of the DAI 
on the eggs number of An. coluzzii
* Significant effect of parameters or interactions (p < 0.05)
Source DF χ2 p value
Treatment 1 48.57 <0.001*
DAI 1 142.77 <0.001*
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and treated sub-sets, respectively: χ21 = 0.044, p = 0.50; 
χ21 = 0.28, p = 0.31; cattle effect for the number of devel-
oped eggs in control and treated sub-sets, respectively: 
χ21 = 32.47, p = 0.18; χ21 = 38.53, p = 0.12).
Infection with Plasmodium falciparum
The experiment included 168 females that had already 
taken a first blood meal on cattle hosts either treated or 
non-treated at 28 DAI, and maintained with 5 % glucose 
solution after their infectious blood meal. Generalized 
linear models did not reveal any significant impact of 
the first ivermectin-rich blood meal on the prevalence or 
intensity of An. coluzzii infection by P. falciparum para-
sites (Table 3). Indeed, females previously fed on control 
or treated cattle had equivalent infection prevalence and 
intensity (respectively, 0.73  ±  0.04 and 3.72  ±  0.38 for 
females fed on controls, and 0.73 ± 0.05 and 4.07 ± 0.56 
for females fed on treated cattle).
Discussion
Therapeutic doses of ivermectin injected to local Bur-
kinabé Metis cattle rendered blood meals toxic to sym-
patric An. coluzii females and reduced both survivorship 
and fecundity of the mosquitoes feeding on treated ani-
mals for up to 28  days. For the 2  weeks following the 
treatment, mean survival time of mosquitoes that fed 
on treated cattle was two to 3.5  days (corresponding to 
a time to 100  % mortality of 3–5.5  days), meaning that 
the great majority would die before being able to resume 
a new gonotrophic cycle by biting a host, achieve sporo-
gony, and eventually transmit malaria parasites. Mos-
quitocidal effect of ivermectin was not complete the 
third and fourth week after treatment and a proportion 
of mosquitoes was able to survive. Yet, 100  % mortality 
was achieved in 17 and 19  days, a timeframe just long 
enough to become infectious and potentially transmit 
the parasite only once (considering that the first blood-
meal was infectious and considering a sporogony last-
ing 12 days in average). Using the same scenario, control 
mosquitoes would survive for 27  days in average, and 
would be infectious through at least three gonotrophic 
cycles. Moreover, the fecundity of mosquitoes fed at 21 
and 28 DAI was significantly reduced by 33 and 20  %, 
respectively. Mosquitoes weren’t allowed to lay their eggs 
nor the hatching rate and larvae survival followed, which 
represent a limitation of this study, probably leading to an 
under-estimation of the ivermectin treatments effects on 
mosquito’s fitness. Considering that a mosquito becomes 
infectious on average 12 days after gametocyte ingestion 
[39], corrected mortalities [40], i.e., 100 × (% dead mos-
quitoes fed on treated cattle − % of dead mosquitoes fed 
on control cattle)/(100 − % dead mosquitoes fed on con-
trol cattle) were 75 and 45 % at 21 and 28 days post injec-
tion, respectively. For up to 1 month, more than half of 
the mosquitoes would die before being able to transmit 
malaria parasites if they were blood fed on treated cat-
tle before or the same day as the infectious blood meal. 
Moreover, a second ivermectin blood meal at sub-lethal 
concentrations further increased the mortality, so much 
that cumulative mosquito mortality was 100 % by day 12 
after the second meal.
As previously reported [5, 14, 15, 41], the present study 
confirms that ivermectin reduces both the life span and 
fecundity of important and dominant malaria vectors 
of sub-Saharan Africa feeding on ivermectin-treated 
hosts. The mosquitocidal effect vanishes at different 
rates between calves, suggesting a fair variability in the 
kinetic and dynamic processes of ivermectin distribution, 
metabolism or clearance, which may impact on the com-
pound availability in peripheral blood vessels. In a recent 
study, a greater availability of ivermectin was reported 
in female human volunteers, which has been associated 
with the greater body mass indices of female by compari-
son to male participants [15]. Although ivermectin is the 
less lipophilic of the macrolactones used as antiparasitic 
compounds, it nevertheless concentrates particularly in 
8212
DAI
nu
m
be
r o
f e
gg
s 
pe
r g
ra
vi
d 
fe
m
al
e
0
20
40
60
80
100
120
140
Fig. 3 Number of eggs developed by gravid females Anopheles 
coluzzii fed on treated and control cattle at 21 and 28 days after injec‑
tion of 200 µg/kg ivermectin. Black bar mosquitoes fed on control 
calves, grey bar mosquitoes fed on treated calves. Error bars are 
standard errors
Table 3 Effects of  sub-lethal dose of  ivermectin on  the 
Plasmodium falciparum gametocytogenesis in An. coluzzii
Source DF χ2 p value
Treatment on infection prevalence 1 0.0003 0.98
Treatment on infection intensity 1 1.33 0.24
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adipose tissues, where the limited vascularization and 
slow turnover rate of fat prolong the residence of the drug 
in the peripheral blood [32] and, therefore, its availability 
to vector mosquitoes. The “slow-release reservoir effect” 
[15] of body fat might also explain why the mosquito-
cidal effect of ivermectin could last more than a month 
in this study while in others, this effect disappeared more 
quickly and is incomplete even shortly after ivermectin 
administration [5, 15]. Subcutaneous injection distrib-
utes a much greater proportion of the ivermectin into 
lipid reservoirs than oral route and increases its residence 
time [42]. Moreover, ivermectin maximum concentra-
tion (Cmax) is much lower when the drug is administrated 
by oral route [43], which might further explain the more 
sustained mosquitocidal effect presented here, but also 
the greater, complete toxicity of the blood meals taken by 
An. coluzzii on treated cattle, for up to 2 weeks after iver-
mectin subcutaneous injection. Interestingly, at the sub-
lethal doses imbibed by mosquitoes at 31 and 37 days, the 
deleterious effects of ivermectin on survival diminished 
after a second blood meal 4  days later, which obviously 
contained ivermectin at less concentration than the first 
[10]. A second blood meal that does not contain or con-
tains less ivermectin than the first has been also shown to 
mitigate the effect of the drug on fecundity and hatch rate 
in Aedes aegypti, Aedes albopictus and Culex quinquefas-
ciatus [44] and on survival in An. gambiae s.s [10]. These 
cumulative effects must be further examined, considering 
malaria vectors proclivities for frequent blood feeding in 
the field [45].
As opposed to in  vitro studies [16], the present study 
failed to demonstrate any transmission blocking prop-
erties of sub-lethal concentrations of ivermectin when 
the ivermectin blood meal was ingested 3  days before 
an infectious blood meal, but yet at a time post injection 
where the drug concentration remains toxic enough to 
impact mosquito survival and fecundity. However, this 
is in line with recent in situ field studies where ivermec-
tin does not impact gametocyte infectivity [15]. Since 
only a single DAI (28 days) has been tested on infection 
prevalence and intensity at the oocyst stage, the present 
study cannot rule out the possibility that ivermectin has 
sporontocidal effects. More experiments are needed 
using different sub-lethal doses, and have to be more 
adequately designed to study the impact of ivermectin 
when imbibed with a blood meal at different times after 
or before the infectious blood meal. However, the present 
results demonstrate that the stress and corresponding fit-
ness costs induced by sub-lethal doses of the drug did not 
positively impact infection output, which could have had 
harmful and counterproductive consequences in terms of 
transmission, jeopardizing further use of ivermectin to 
control vector mosquito populations.
The integrative control measure adjunction to exist-
ing tools offered by ivermectin has a potential for the 
management of insecticide resistance since the mode 
of action of the drug and insecticides currently used 
for vector control are different. However, despite cru-
cial importance, only a few studies have addressed the 
question of potential cross-resistance to ivermectin in 
insecticide-resistant vector mosquitoes. Deus et  al. [46] 
found an increased tolerance to ivermectin imbibed in 
a blood meal in different Ae. aegypti strains resistant to 
pyrethroid insecticides. For An. gambiae s.l., ivermec-
tin decreases mosquito life span of Anopheles in differ-
ent areas of Burkina Faso [14, 15] where the frequency 
of insecticide target-site mutations, including knock-
down resistance (kdr) and insensitive acetylcholinester-
ase (Ace-1R) alleles, has been regularly monitored and 
where detoxifying enzymes also contribute to the diver-
sity of resistant phenotypes observed in the field [47, 48]. 
Thanks to the presence of one out of three mosquitoes 
carrying the mutated kdr allele in the An. coluzzii colony 
used here, this study suggests that no cross-resistance to 
ivermectin exists in kdr carriers, at least at the plasmatic 
concentrations where mosquitocidal effect is complete. 
However, proper phenotypic characterization of mutated 
kdr carriers using bioassays would have been needed to 
actually check the adequacy between the genotype and 
resistance phenotype. Hence, more studies are definitely 
needed to decipher this question, knowing the great 
diversity and complexity of physiological mechanisms 
allowing wild An. gambiae s.l. populations to resist most, 
if not all, of the insecticide classes used to date as vector 
control tools [31, 47].
Ivermectin is of capital importance for the control 
of many parasitic diseases in animals and humans and 
resistance appearance in endo- or ectoparasitic fauna 
classically targeted by ivermectin treatments would rep-
resent a public health disaster. Ivermectin resistance was 
reported in small ruminants and cattle nematodes after 
frequent host treatment [43–45, 49]. Hence, if the “One-
Health” approach was to be implemented as an alterna-
tive method for the control of malaria vectors, a careful 
monitoring of potential resistance appearance must be 
undertaken. Researches must also be prompted to appre-
hend the risk of an emerging resistance to ivermectin in 
Anopheles field populations. Indeed, with a much longer 
mosquitocidal and anti-fecundity effect in cattle serum, 
longer insecticidal pressure from mosquitocidal cattle 
blood could select for ivermectin resistance in Anoph-
eles. Recent attempts have been made to better under-
stand the IVM-mosquitoes interactions, where canonical 
detoxification mechanisms seem to be only marginally 
involved in the mosquito’s response to ivermectin inges-
tion, whereas non-canonical pathways are highlighted, 
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notably those involving Nieman–Pick type C-2 family 
genes [50]. Moreover, the recent discovery of ivermectin 
sensitive and insensitive glutamate-gated chloride chan-
nels generated through alternative splicing, questions 
this mechanism as the potential target of selection for 
ivermectin resistance in the field [17]. These findings are 
important in the sense that they clearly emphasize the 
complexity of IVM-mosquitoes interactions, which need 
to be unravelled to better evaluate the risks of emergence 
of ivermectin resistance in the mosquito populations 
targeted by ivermectin treatments. Similarly, treating 
cattle might select for Anopheles species/populations 
with altered behavior toward increased anthropophagy. 
Hence, the proposed approach would stand only if inte-
grative measures are taken where treatments to humans 
and cattle and their potential consequences are consid-
ered concomitantly. Ivermectin resistance in human or 
animal targeted parasites and in Anopheles populations 
are dark shadows in the board of “One-Health” MDAs, 
and facing these caveats even before they become an 
issue is the only way to leave this promising approach a 
reality.
Although subcutaneous administration of ivermec-
tin generates lower faeces concentrations of the product 
when compared to oral or poor-on formulations [32], 
non-targeted coprophagic fauna could especially be at 
risk if MDAs to livestock were implemented [51]. Dung 
pats are widely used for agricultural purposes in rural 
Burkina Faso, as everywhere in sub-Saharan rural Africa. 
Coprophagic fauna accelerate the degradation of dung 
pats and maintain soil productivity by enhancing the 
activity of the micro-organisms therein that participate 
in the mineralization of animal waste. Even sub-lethal 
doses of ivermectin induce an acute toxicity, altering the 
sensory and locomotor capacities of dung beetles, and 
preventing their basic biological activities, ultimately 
leading to their premature death [52]. However, know-
ing that sensitivity to ivermectin may vary among spe-
cies of the same taxa [53], further studies are needed to 
properly assess ivermectin sensitivity of the coprophagic 
fauna present in the areas targeted for the “One-health 
approach”. Such studies are needed so the health ben-
efits to humans and animals of integrated MDAs will 
not be hampered by potentially high economic losses, 
which might mitigate the acceptation of this approach by 
communities.
Conclusion
This study indicates a sustained, complete effect of iver-
mectin on the survival of recently colonized An. coluzzii 
females after blood feeding on local calves treated sub-
cutaneously with the recommended therapeutic dose. 
Moreover, effects of sub-lethal doses are observed on 
mosquito fecundity, which further increases the impact 
of ivermectin administrated to cattle on total vector den-
sities. This effect might be even larger than reported here 
due to the known deleterious effects of sub-lethal doses 
of ivermectin on mosquito physiology and behaviour, 
hampering mosquito survival in the field. Further, this 
study demonstrates the potential of integrated MDAs 
of ivermectin to both human and peridomestic cattle to 
target anthropophilic, endophagic, but also exophilic and 
zoophagic mosquitoes in areas where both physiological 
and behavioural resistances are widespread, building res-
ervoirs of residual malaria transmission.
At the approved dose of 200  μg/kg used by medical 
and veterinary services, current oral formulations can 
only maintain efficient mosquitocidal concentrations for 
approximately 2–4 days [15], while injected formulations 
to cattle do so for up to 2  weeks. Interrupting malaria 
transmission would require a more prolonged mosquito-
cidal effect [54], which could be obtained either through 
the distribution of multiple doses of ivermectin, or 
through the administration of a slow-release formulation, 
for which research work is on-going [55].
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